iconEarnings Announcement After Market Close

LeMaitre Vascular Inc LMAT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:56 AM EDT
65.94quote price arrow down-0.84 (-1.26%)
Volume
28,911
52 week range
44.27 - 74.64
Loading...
  • Open66.78
  • Day High67.56
  • Day Low65.16
  • Prev Close66.78
  • 52 Week High74.64
  • 52 Week High Date02/28/24
  • 52 Week Low44.27
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.48B
  • Shares Out22.45M
  • 10 Day Average Volume0.12M
  • Dividend0.64
  • Dividend Yield0.97%
  • Beta0.85
  • YTD % Change16.3

KEY STATS

  • Open66.78
  • Day High67.56
  • Day Low65.16
  • Prev Close66.78
  • 52 Week High74.64
  • 52 Week High Date02/28/24
  • 52 Week Low44.27
  • 52 Week Low Date10/27/23
  • Market Cap1.48B
  • Shares Out22.45M
  • 10 Day Average Volume0.12M
  • Dividend0.64
  • Dividend Yield0.97%
  • Beta0.85
  • YTD % Change16.3

RATIOS/PROFITABILITY

  • EPS (TTM)1.34
  • P/E (TTM)49.12
  • Fwd P/E (NTM)39.89
  • EBITDA (TTM)46.712M
  • ROE (TTM)10.64%
  • Revenue (TTM)193.484M
  • Gross Margin (TTM)65.66%
  • Net Margin (TTM)15.56%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date03/13/2024
  • Div Amount0.16
  • Split Date-
  • Split Factor-

Latest On LeMaitre Vascular Inc

 

Profile

MORE
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue...
George LeMaitre
Chairman of the Board, Chief Executive Officer
David Roberts
President, Director
Joseph Pellegrino Jr.
Chief Financial Officer, Director
Giovannella Deiure
Vice President - Sales, Southern Europe
Helen Goulding
Vice President - Sales, Northern Europe
Address
63 2nd Ave
Burlington, MA
01803-4413
United States

Top Peers

SYMBOLLASTCHG%CHG
ESTA
Establishment Labs Holdings Inc
49.25-1.36-2.69%
CTKB
Cytek Biosciences Inc
6.31-0.06-0.94%
SILK
Silk Road Medical Inc
19.37-0.79-3.92%
FNA
Paragon 28 Inc
10.03+0.17+1.72%
TMCI
Treace Medical Concepts Inc
10.73-0.13-1.20%